يعرض 1 - 10 نتائج من 81 نتيجة بحث عن '"Marco, Carla"', وقت الاستعلام: 1.76s تنقيح النتائج
  1. 1
    دورية أكاديمية
  2. 2
    رسالة جامعية

    المؤلفون: Marco, Carla Fernanda de

    مرشدي الرسالة: Garcia, Maria

    المصدر: Biblioteca Digital de Teses e Dissertações da PUC_SPPontifícia Universidade Católica de São PauloPUC_SP.

    وصف الملف: application/pdf

  3. 3
    دورية أكاديمية
  4. 4
    دورية أكاديمية

    المساهمون: Universitat Politècnica de València. Escuela Politécnica Superior de Alcoy - Escola Politècnica Superior d'Alcoi, Comunidad de Madrid, Instituto de Salud Carlos III, Fundación Atrofia Muscular Espinal, Centro de Investigación Biomédica en Red de Enfermedades Raras

    العلاقة: European Journal of Neurology; info:eu-repo/grantAgreement/ISCIII/Plan Estatal de Investigación Científica y Técnica y de Innovación 2017-2020 (ISCIII)/PI21%2F00737/ES/PAPEL DE LA GENETICA, LA MICROBIOTA Y LOS BIOMARCADORES DE NEURODEGENERACION E INFLAMACION EN EL DESARROLLO DE LA MEDICINA DE PRECISIÓN APLICADA A LA ELA/; info:eu-repo/grantAgreement/CAM//PIC188-18//Proyecto Cuídame para la atención de personas mayores de pequeños municipios de hasta 250 habitantes/; info:eu-repo/grantAgreement/ISCIII//19%2F01178/; info:eu-repo/grantAgreement/ISCIII//JR19%2F00030/; info:eu-repo/grantAgreement/ISCIII//21%2F00737/; info:eu-repo/grantAgreement/FundAME//FUN-000-2017-01/; https://doi.org/10.1111/ene.15542Test; urn:issn:1351-5101; http://hdl.handle.net/10251/199839Test; PMC9826246

  5. 5
    دورية أكاديمية
  6. 6
    دورية أكاديمية
  7. 7
    دورية أكاديمية
  8. 8
    دورية أكاديمية

    المساهمون: Andrés-Benito, Pol, Department of Pathology and Experimental Therapeutics, University of Barcelona, Feixa Llarga s/n, 08907 L’Hospitalet de Llobregat, Barcelona, Spain, pol.andres.benito@gmail.com Biomedical Network Research Center on Neurodegenerative Diseases (CIBERNED), Institute Carlos III, Feixa Llarga s/n, 08907 L’Hospitalet de Llobregat, Barcelona, Spain, pol.andres.benito@gmail.com Bellvitge Biomedical Research Institute (IDIBELL), 08907 L’Hospitalet de Llobregat, Barcelona, Spain, pol.andres.benito@gmail.com Institute of Neurosciences, University of Barcelona, 08907 L’Hospitalet de Llobregat, Barcelona, Spain, pol.andres.benito@gmail.com International Initiative for Treatment and Research Initiative to Cure ALS (TRICALS), Bellvitge University Hospital, 08907 Hospitalet de Llobregat, Spain, pol.andres.benito@gmail.com, Povedano, Mònica, International Initiative for Treatment and Research Initiative to Cure ALS (TRICALS), Bellvitge University Hospital, 08907 Hospitalet de Llobregat, Spain, mpovedano@bellvitgehospital.cat Functional Unit of Amyotrophic Lateral Sclerosis (UFELA), Service of Neurology, Bellvitge University Hospital, 08907 L’Hospitalet de Llobregat, Barcelona, Spain, mpovedano@bellvitgehospital.cat, Domínguez, Raúl, International Initiative for Treatment and Research Initiative to Cure ALS (TRICALS), Bellvitge University Hospital, 08907 Hospitalet de Llobregat, Spain, rdominguez@bellvitgehospital.cat, Marco, Carla, International Initiative for Treatment and Research Initiative to Cure ALS (TRICALS), Bellvitge University Hospital, 08907 Hospitalet de Llobregat, Spain, carlamarcocazcarra@gmail.com, Colomina, Maria J., Anesthesia and Critical Care Department, Bellvitge University Hospital-University of Barcelona, 08907 L’Hospitalet de Llobregat, Barcelona, Spain, Mjcolomina@gmail.com, López-Pérez, Óscar, Biomedical Network Research Center on Neurodegenerative Diseases (CIBERNED), Institute Carlos III, Feixa Llarga s/n, 08907 L’Hospitalet de Llobregat, Barcelona, Spain, oscarlzpz@gmail.com, Santana, Isabel, Neurology Department, CHUC—Centro Hospitalar e Universitário de Coimbra, CNC—Center for Neuroscience and Cell Biology, and Faculty of Medicine, University of Coimbra, 3000-456 Coimbra, Portugal, isabeljsantana@gmail.com, Baldeiras, Inês, and Faculty of Medicine, University of Coimbra, 3000-456 Coimbra, Portugal, ines.baldeiras@sapo.pt, Martínez-Yelámos, Sergio, Multiple Sclerosis Unit, Service of Neurology, Bellvitge University Hospital, 08907 L’Hospitalet de Llobregat, Barcelona, Spain, smartinezy@bellvitgehospital.cat, Zerr, Inga, Department of Neurology, University Medical Center Göttingen, 37075 Göttingen, Germany, ingazerr@med.uni-goettingen.de German Center for Neurodegenerative Diseases (DZNE), 37075 Göttingen, Germany, ingazerr@med.uni-goettingen.de, Llorens, Franc, Department of Pathology and Experimental Therapeutics, University of Barcelona, Feixa Llarga s/n, 08907 L’Hospitalet de Llobregat, Barcelona, Spain, franc.llorens@gmail.com Biomedical Network Research Center on Neurodegenerative Diseases (CIBERNED), Institute Carlos III, Feixa Llarga s/n, 08907 L’Hospitalet de Llobregat, Barcelona, Spain, franc.llorens@gmail.com Bellvitge Biomedical Research Institute (IDIBELL), 08907 L’Hospitalet de Llobregat, Barcelona, Spain, franc.llorens@gmail.com Institute of Neurosciences, University of Barcelona, 08907 L’Hospitalet de Llobregat, Barcelona, Spain, franc.llorens@gmail.com, Fernández-Irigoyen, Joaquín, IDISNA, Navarra Institute for Health Research, 31008 Pamplona, Spain, joaquin.fernandez.irigoyen@navarra.es Clinical Neuroproteomics Unit, Proteomics Platform, Proteored-ISCIII, Navarrabiomed, Complejo Hospitalario de Navarra (CHN), Universidad Pública de Navarra (UPNA), 31008 Pamplona, Spain, joaquin.fernandez.irigoyen@navarra.es, Santamaría, Enrique, IDISNA, Navarra Institute for Health Research, 31008 Pamplona, Spain, enrique.santamaria.martinez@navarra.es Clinical Neuroproteomics Unit, Proteomics Platform, Proteored-ISCIII, Navarrabiomed, Complejo Hospitalario de Navarra (CHN), Universidad Pública de Navarra (UPNA), 31008 Pamplona, Spain, enrique.santamaria.martinez@navarra.es, Ferrer, Isidro, Department of Pathology and Experimental Therapeutics, University of Barcelona, Feixa Llarga s/n, 08907 L’Hospitalet de Llobregat, Barcelona, Spain, 8082ifa@gmail.com Biomedical Network Research Center on Neurodegenerative Diseases (CIBERNED), Institute Carlos III, Feixa Llarga s/n, 08907 L’Hospitalet de Llobregat, Barcelona, Spain, 8082ifa@gmail.com Bellvitge Biomedical Research Institute (IDIBELL), 08907 L’Hospitalet de Llobregat, Barcelona, Spain, 8082ifa@gmail.com Institute of Neurosciences, University of Barcelona, 08907 L’Hospitalet de Llobregat, Barcelona, Spain, 8082ifa@gmail.com International Initiative for Treatment and Research Initiative to Cure ALS (TRICALS), Bellvitge University Hospital, 08907 Hospitalet de Llobregat, Spain, 8082ifa@gmail.com Neuropathology, Pathologic Anatomy Service, Bellvitge University Hospital, 08907 L’Hospitalet de Llobregat, Barcelona, Spain, 8082ifa@gmail.com

  9. 9
    دورية أكاديمية

    المساهمون: Institut Català de la Salut, Sánchez-Cirera L Fellow of Neurology, Stroke Unit, Departament de Neurologia, Hospital Universitari de Girona Dr. Josep Trueta, Institut Català de la Salut (ICS), Girona, Spain. Bashir S, Marco C, Terceño M, Silva Y Neurologist, Stroke Unit, Departament de Neurologia, Hospital Universitari de Girona Dr. Josep Trueta, Institut Català de la Salut (ICS), Girona, Spain. Institut d'Investigació Biomèdica de Girona Dr. Josep Trueta (IDIBGI), Girona, Spain. Ciscar A Student of Medicine, Medicine Faculty, University of Girona, Girona, Spain. Cruz V Nurse of Neurology, Stroke Unit, Departament de Neurologia, Hospital Universitari de Girona Dr. Josep Trueta, Institut Català de la Salut (ICS), Girona, Spain. Serena J Departament de Neurologia, Hospital Universitari de Girona Doctor Josep Trueta, Institut Català de la Salut (ICS), Girona, Spain. Institut d'Investigació Biomèdica de Girona Dr. Josep Trueta (IDIBGI), Girona, Spain, Departament de Salut

    المصدر: Scientia

    وصف الملف: application/pdf

    العلاقة: PLoS One;16(12); https://doi.org/10.1371/journal.pone.0261080Test; Sánchez-Cirera L, Bashir S, Ciscar A, Marco C, Cruz V, Terceño M, et al. Prevalence of the Frank's sign by aetiopathogenic stroke subtype: A prospective analysis. PLoS One. 2021 Dec 15;16(12):e0261080.; https://hdl.handle.net/11351/6987Test

  10. 10
    دورية أكاديمية